Study of clinical and patient-reported outcomes in adults with moderate to severe COPD treated with Breztri/Trixeo

Trial Identifier: D5980R00128
Sponsor: AstraZeneca
Start Date: December 2025
Primary Completion Date: September 2027
Study Completion Date: September 2027
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
EGYPT, Egypt Alexandria, Egypt, EGYPT
EGYPT, Egypt Cairo, Egypt, EGYPT
Saudi Arabia, Saudi Arabia Abha, Saudi Arabia, Saudi Arabia
Saudi Arabia, Saudi Arabia Riyadh, Saudi Arabia, Saudi Arabia
Taiwan, Taiwan Taichung, Taiwan, Taiwan
Taiwan, Taiwan Tainan, Taiwan, Taiwan
Taiwan, Taiwan Taipei, Taiwan, Taiwan
Taiwan, Taiwan Yunlin, Taiwan, Taiwan
Vietnam, Vietnam Ha Noi City, Vietnam, Vietnam
Vietnam, Vietnam Ho Chi Minh City, Vietnam, Vietnam